Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report

COVID-19 Vaccine India: More than 41.69 crore vaccine doses have been provided to states and UTs so far, the health ministry said today.

The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said. They said 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from Bharat Biotech will be procured by December. "An order to procure 66 crore more doses of COVID-19 vaccines--Covishield and Covaxin--to be supplied between August and December, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, has been placed," the source told news agency Press Trust of India. The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes, it said.